Skip to Main Content
Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We look forward to another installment in our “Let’s-see-them-before-they-die” concert series, organize our library, and hang with our short person. And what about you? This remains a lovely time to enjoy the great outdoors. You could hunt for apples or pumpkins. Look ahead to a winter getaway. Or check to see how much health insurance you will have next year. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

Avanir Pharmaceuticals (AVNR) is raking in hundreds of millions of dollars a year by aggressively targeting elderly nursing home residents for whom its Nuedextra pill may be unnecessary or even unsafe, CNN reports. The drug is approved to treat a disorder marked by sudden and uncontrollable laughing or crying, but not extensively studied in elderly patients. Since 2012, more than half of all Nuedexta pills have gone to long-term care facilities.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • As a frequent nursing home visitor what I’ve witnessed is uncontrollable staccato bursts of anger from the relatives who visit once a year from Florida and stay long enough to find fault in virtually everything.

Comments are closed.